Kimmo Suokas

Kimmo Suokas

Auto-generated profile, based on publicly available information

Kimmo Suokas

University of Helsinki

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Psychiatric Services
Verified
Journal Article
Closed access
CHChristian Hakulinen
Christian Hakulinen
MEMarko Elovainio
Marko Elovainio
MAMartti Arffman
Martti Arffman
SLSonja Lumme
Sonja Lumme
KSKimmo Suokas
Kimmo Suokas
PBPetri Böckerman
Petri Böckerman

27 July 2011 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
KSKimmo I. Suokas
Kimmo I. Suokas
MHMaija Haanpää
Maija Haanpää
HKHannu Kautiainen
Hannu Kautiainen
BUBjarne Udd
Bjarne Udd
AHAki J. Hietaharju
Aki J. Hietaharju

1 March 2020 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
KSKimmo Suokas
Kimmo Suokas
AKAnna-Maija Koivisto
Anna-Maija Koivisto
CHChristian Hakulinen
Christian Hakulinen
RKRiittakerttu Kaltiala
Riittakerttu Kaltiala
RSReijo Sund
Reijo Sund
SPSami Pirkola
Sami Pirkola
The negative association between household income and different mental health outcomes has been observed repeatedly,1-8 but not always.9-12 Significant differences in health and mortality are found between all socioeconomic levels of society, which is often referred to as the social gradient in health.13,14 This pattern has its roots in childhood15,16 and has been observed in some studies of common mental disorders.8,17 However, some studies18-20 argue that, after basic needs are met, additional income is not associated with increases in well-being. At present, whether there is an income gradient in the incidence rates of first hospital-treated mental disorders is unknown.

6 February 2023 in Journal of Epidemiology and Community Health
Verified
Journal Article
Open access
PDF file
CHChristian Hakulinen
Christian Hakulinen
KKKaisla Komulainen
Kaisla Komulainen
KSKimmo Suokas
Kimmo Suokas
SPSami Pirkola
Sami Pirkola
LPLaura Pulkki-Råback
Laura Pulkki-Råback
Petri BöckermanPetri Böckerman
Petri Böckerman
Background A study was undertaken to examine the association between multiple indicators of socioeconomic position (SEP) at the age of 30 and the subsequent risk of the most common mental disorders. Methods All persons born in Finland between 1966 and 1986 who were alive and living in Finland at the end of the year when they turned 30 were included. Educational attainment, employment status and personal total income were used as the alternative measures of SEP. Cox proportional hazards models were used to examine the association of SEP at the age of 30 with later risk of mental disorders. Additional analyses were conducted using a sibling design to account for otherwise unobserved shared family characteristics. Competing risks models were used to estimate absolute risks. Results The study population included 1 268 768 persons, 26% of whom were later diagnosed with a mental disorder. Lower SEP at age 30 was consistently associated with a higher risk of being later diagnosed with a mental disorder, even after accounting for shared family characteristics and prior history of a mental disorder. Diagnosis-specific analyses showed that the associations were considerably stronger when substance misuse or schizophrenia spectrum disorders were used as an outcome. Absolute risk analyses showed that, by the age of 52 years, 58% of persons who had low educational attainment at the age of 30 were later diagnosed with a mental disorder. Conclusions Poor SEP at the age of 30 is associated with an increased risk of being later diagnosed with a mental disorder.

23 February 2022 in The Pharmacogenomics Journal
Verified
Journal Article
Open access
PDF file
KHKatja Häkkinen
Katja Häkkinen
JKJohanna I. Kiiski
Johanna I. Kiiski
MLMarkku Lähteenvuo
Markku Lähteenvuo
TJTuomas Jukuri
Tuomas Jukuri
KSKimmo Suokas
Kimmo Suokas
AAAri V. Ahola-Olli
Ari V. Ahola-Olli
We demonstrate that CYP2D6 copy-number variation (CNV) can be imputed using existing imputation algorithms. Additionally, we report frequencies of key pharmacogenetic variants in individuals with a psychotic disorder from the genetically bottle-necked population of Finland. We combined GWAS chip and CYP2D6 CNV data from the Breast Cancer Pain Genetics study to construct an imputation panel (n = 902) for CYP2D6 CNV. The resulting data set was used as a CYP2D6 CNV imputation panel in 9262 non-related individuals from the SUPER-Finland study. Based on imputation of 9262 individuals we confirm the higher frequency of CYP2D6 ultrarapid metabolizers and a 22-fold enrichment of the UGT1A1 decreased function variant rs4148323 (UGT1A1*6) in Finland compared with non-Finnish Europeans. Similarly, the NUDT15 variant rs116855232 was highly enriched in Finland. We demonstrate that imputation of CYP2D6 CNV is possible and the methodology enables studying CYP2D6 in large biobanks with genome-wide data.

12 April 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
MLMarkku Lähteenvuo
Markku Lähteenvuo
AAAri Ahola-Olli
Ari Ahola-Olli
KSKimmo Suokas
Kimmo Suokas
MHMinna Holm
Minna Holm
ZMZuzanna Misiewicz
Zuzanna Misiewicz
APAarno Palotie
Aarno Palotie
Purpose SUPER-Finland is a large Finnish collection of psychosis cases. This cohort also represents the Finnish contribution to the Stanley Global Neuropsychiatric Genetics Initiative, which seeks to diversify genetic sample collection to include Asian, Latin American and African populations in addition to known population isolates, such as Finland. Participants 10 474 individuals aged 18 years or older were recruited throughout the country. The subjects have been genotyped with a genome-wide genotyping chip and exome sequenced. A subset of 897 individuals selected from known population sub-isolates were selected for whole-genome sequencing. Recruitment was done between November 2015 and December 2018. Findings to date 5757 (55.2%) had a diagnosis of schizophrenia, 944 (9.1%) schizoaffective disorder, 1612 (15.5%) type I or type II bipolar disorder, 532 (5.1 %) psychotic depression, 1047 (10.0%) other psychosis and for 530 (5.1%) self-reported psychosis at recruitment could not be confirmed from register data. Mean duration of schizophrenia was 22.0 years at the time of the recruitment. By the end of the year 2018, 204 of the recruited individuals had died. The most common cause of death was cardiovascular disease (n=61) followed by neoplasms (n=40). Ten subjects had psychiatric morbidity as the primary cause of death. Future plans Compare the effects of common variants, rare variants and copy number variations (CNVs) on severity of psychotic illness. In addition, we aim to track longitudinal course of illness based on nation-wide register data to estimate how phenotypic and genetic differences alter it.